ZA962633B - Taxoids their preparation and pharmaceutical compositions containing them - Google Patents

Taxoids their preparation and pharmaceutical compositions containing them

Info

Publication number
ZA962633B
ZA962633B ZA962633A ZA962633A ZA962633B ZA 962633 B ZA962633 B ZA 962633B ZA 962633 A ZA962633 A ZA 962633A ZA 962633 A ZA962633 A ZA 962633A ZA 962633 B ZA962633 B ZA 962633B
Authority
ZA
South Africa
Prior art keywords
taxoids
preparation
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
ZA962633A
Other languages
English (en)
Inventor
Herve Bouchard
Jean-Dominique Bourzat
Alain Commercon
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA962633B publication Critical patent/ZA962633B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA962633A 1995-04-03 1996-04-02 Taxoids their preparation and pharmaceutical compositions containing them ZA962633B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9503868A FR2732342B1 (fr) 1995-04-03 1995-04-03 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA962633B true ZA962633B (en) 1996-10-07

Family

ID=9477663

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA962633A ZA962633B (en) 1995-04-03 1996-04-02 Taxoids their preparation and pharmaceutical compositions containing them

Country Status (32)

Country Link
US (1) US5959125A (cs)
EP (1) EP0821680B1 (cs)
JP (1) JPH11504004A (cs)
KR (1) KR19980703520A (cs)
CN (1) CN1073106C (cs)
AP (1) AP784A (cs)
AR (1) AR002730A1 (cs)
AT (1) ATE195940T1 (cs)
AU (1) AU703918B2 (cs)
BG (1) BG62964B1 (cs)
BR (1) BR9604799A (cs)
CA (1) CA2214322C (cs)
CZ (1) CZ287430B6 (cs)
DE (1) DE69610085T2 (cs)
DK (1) DK0821680T3 (cs)
EA (1) EA000726B1 (cs)
ES (1) ES2151155T3 (cs)
FR (1) FR2732342B1 (cs)
GE (1) GEP19991872B (cs)
GR (1) GR3034203T3 (cs)
HU (1) HUP9802042A3 (cs)
IL (1) IL117760A (cs)
MX (1) MX9707427A (cs)
NO (1) NO974563L (cs)
NZ (1) NZ305898A (cs)
PL (1) PL322581A1 (cs)
PT (1) PT821680E (cs)
RO (1) RO115879B1 (cs)
SK (1) SK282047B6 (cs)
TW (1) TW347389B (cs)
WO (1) WO1996031493A1 (cs)
ZA (1) ZA962633B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
FR2764118B1 (fr) * 1997-05-30 2000-08-04 Thomson Csf Transistor bipolaire stabilise avec elements isolants electriques
US6156789A (en) * 1998-03-17 2000-12-05 Rhone-Poulenc Rorer S.A. Method for treating abnormal cell proliferation in the brain
EP1176957A1 (en) * 1999-05-03 2002-02-06 Aventis Pharma S.A. Method for treating abnormal cell proliferation in the brain
HUP0200759A3 (en) 2000-02-02 2002-10-28 Univ Florida State Res Found C10 carbonate substituted taxanes as antitumor agents and pharmaceutical compositions containing them and their use
US6649632B2 (en) * 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
PL350331A1 (en) * 2000-02-02 2002-12-02 Univ Florida State Res Found C10 carbamoyloxy substituted taxanes as antitumor agents
JP2004339475A (ja) * 2003-02-03 2004-12-02 Merck Patent Gmbh フッ化物、オキシフッ化物、フルオロ硫化物および/またはオキシフルオロ硫化物に基づく真珠光沢顔料
CA2526278A1 (en) * 2003-05-20 2004-12-02 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
HN2005000054A (es) * 2004-02-13 2009-02-18 Florida State University Foundation Inc Taxanos sustituidos con esteres de ciclopentilo en c10
CA2597682A1 (en) * 2005-02-14 2006-08-24 Florida State University Research Foundation, Inc. C10 cyclopropyl ester substituted taxane compositions
WO2009145981A1 (en) * 2008-03-31 2009-12-03 Florida State University Research Foundation, Inc. C(10) ethyl ester and c(10) cyclopropyl ester substituted taxanes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO302520B1 (no) * 1992-07-01 1998-03-16 Bristol Myers Squibb Co Fluortaxoler, mellomprodukt til fremstilling derav, samt farmasöytisk preparat inneholdende dem
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
FR2698871B1 (fr) * 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
MX9307777A (es) * 1992-12-15 1994-07-29 Upjohn Co 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.

Also Published As

Publication number Publication date
CZ287430B6 (en) 2000-11-15
SK133397A3 (en) 1998-02-04
GR3034203T3 (en) 2000-11-30
CZ310997A3 (cs) 1998-01-14
JPH11504004A (ja) 1999-04-06
DE69610085D1 (de) 2000-10-05
BG62964B1 (bg) 2000-12-29
US5959125A (en) 1999-09-28
DE69610085T2 (de) 2001-01-11
AP9701094A0 (en) 1997-10-31
FR2732342A1 (fr) 1996-10-04
IL117760A0 (en) 1996-08-04
AR002730A1 (es) 1998-04-29
NO974563D0 (no) 1997-10-02
PL322581A1 (en) 1998-02-02
AP784A (en) 1999-11-22
BR9604799A (pt) 1999-04-06
CN1073106C (zh) 2001-10-17
WO1996031493A1 (fr) 1996-10-10
NO974563L (no) 1997-11-24
TW347389B (en) 1998-12-11
CA2214322A1 (fr) 1996-10-10
AU703918B2 (en) 1999-04-01
GEP19991872B (en) 1999-12-06
NZ305898A (en) 1998-12-23
EA000726B1 (ru) 2000-02-28
PT821680E (pt) 2000-12-29
EP0821680A1 (fr) 1998-02-04
AU5402896A (en) 1996-10-23
IL117760A (en) 2001-11-25
ES2151155T3 (es) 2000-12-16
MX9707427A (es) 1998-02-28
FR2732342B1 (fr) 1997-04-30
EP0821680B1 (fr) 2000-08-30
SK282047B6 (sk) 2001-10-08
CN1179777A (zh) 1998-04-22
KR19980703520A (ko) 1998-11-05
HUP9802042A2 (hu) 2000-06-28
ATE195940T1 (de) 2000-09-15
DK0821680T3 (da) 2000-11-20
CA2214322C (fr) 2007-01-30
RO115879B1 (ro) 2000-07-28
HUP9802042A3 (en) 2001-02-28
EA199700288A1 (ru) 1998-04-30
BG101940A (en) 1998-11-30

Similar Documents

Publication Publication Date Title
ZA962399B (en) Taxoids their preparation and pharmaceutical compositions containing them
ZA9610737B (en) Taxoids their preparation and pharmaceutical compositions containing them
IL117860A0 (en) Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them
IL122293A0 (en) Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
IL122618A0 (en) Substituted imidazolylacetonitrile compounds their preparation and pharmaceutical compositions containing them
IL119559A0 (en) Purin -6- one derivatives their preparation and pharmaceutical compositions containing them
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
IL117878A (en) Taxoids their preparation and pharmaceutical compositions containing them
IL117815A0 (en) Ascomycins their preparation and pharmaceutical compositions containing them
IL123322A0 (en) Tetrahydroquinolines their preparation and pharmaceutical compositions containing them
IL125998A0 (en) Taxoids preparation thereof and pharmaceutical compositions containing them
ZA948789B (en) Novel taxoids their preparation and pharmaceutical compositions which contain them
ZA962633B (en) Taxoids their preparation and pharmaceutical compositions containing them
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
IL118672A (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
HUP9801751A3 (en) Benzopyrans their preparation and use and pharmaceutical compositions containing them
IL114623A0 (en) Substituted triazolylmethylphenylnaph-thyridones their preparation and pharmaceutical compositions containing them
IL113415A (en) Dihydrodibenziso-quinolinediones their preparation and pharmaceutical compositions containing them
IL124415A (en) N, n'-bridged bisindolylmaleimides, their preparation and pharmaceutical compositions containing them
ZA962400B (en) Taxoids their preparation and pharmaceutical compositions containing them
ZA9610740B (en) Taxoids their preparation and pharmaceutical compositions containing them
IL123000A (en) Aza-anthracylinone derivatives their preparation and pharmaceutical compositions containing them
IL119136A0 (en) Heterocyclically substituted pseudopeptides their preparation and pharmaceutical compositions containing them
SI0817779T1 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same